Keyphrases
Cardiovascular Outcomes
100%
Systematic Meta-analysis
100%
Meta-analysis of Randomized Controlled Trials
100%
Outcome Mortality
100%
Polypill
100%
Primary Prevention
33%
CVD Events
33%
Cardiovascular Risk
22%
Low Risk
22%
All-cause Mortality
22%
Systolic Blood Pressure
11%
Diastolic Blood Pressure
11%
Adverse Events
11%
Significant Risk Factors
11%
Risk Factors
11%
Cardiovascular Risk Reduction
11%
Secondary Prevention
11%
Pooled Analysis
11%
Low-density Lipoprotein Cholesterol (LDL-C)
11%
Risk Reduction
11%
Population Level
11%
Disease Burden
11%
Major Adverse Cardiovascular Events
11%
Risk Ratio
11%
Random Effects Model
11%
Baseline Risk
11%
Comprehensive Assessment
11%
Risk Prevention
11%
Drug Discontinuation
11%
Cardiovascular Disease Events
11%
Adverse Drug
11%
Lower Primary
11%
Random Effects Modelling
11%
Continuous Outcomes
11%
Dichotomous Outcomes
11%
Drug Adherence
11%
Inverse-variance Weights
11%
Medicine and Dentistry
Systematic Review
100%
Cardiovascular System
100%
Meta-Analysis
100%
Randomized Controlled Trial
100%
Polypill
100%
Cardiovascular Disease
55%
Primary Prevention
33%
Cardiovascular Disease Risk Factor
22%
Risk Reduction
22%
All Cause Mortality
22%
Systolic Blood Pressure
11%
Adverse Event
11%
Population Research
11%
Side Effect
11%
Pooled Analysis
11%
Low Density Lipoprotein Cholesterol
11%
Secondary Prevention
11%
Diastolic Blood Pressure
11%
Random Effects Model
11%
Medication Compliance
11%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Cardiovascular Disease
100%
All Cause Mortality
28%
Adverse Event
14%
Low Density Lipoprotein Cholesterol
14%
Side Effect
14%
Population Study
14%
Random Effects Model
14%